Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study

OBJECTIVE: In the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, metformin plus rosiglitazone (M + R) maintained glycemic control better than metformin alone (M) or metformin plus lifestyle (M + L) in youth with type 2 diabetes (T2D). We hypothesized that changes in vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Dhaliwal, Ruban, Shepherd, John A., El ghormli, Laure, Copeland, Kenneth C., Geffner, Mitchell E., Higgins, Janine, Levitsky, Lynne L., Nadeau, Kristen J., Weinstock, Ruth S., White, Neil H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2019
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647052/
https://ncbi.nlm.nih.gov/pubmed/31167889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-1935
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados